Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Applied Therapeutics, Inc. APLT |
BlackRock Inc. BLK |
6,942,699 6.000% |
6,942,699 (New Position) |
Filing History |
| 2024-08-14 6:52 pm Sale |
2024-08-12 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 7,803,355 6.600% |
-843,536 (-9.76%) |
Filing History |
| 2024-03-08 3:17 pm Purchase |
2024-03-01 | 13G | Applied Therapeutics, Inc. APLT |
JANUS HENDERSON GROUP PLC JHG |
6,414,642 6.100% |
6,414,642 (New Position) |
Filing History |
| 2024-03-05 5:42 pm Purchase |
2024-03-01 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 8,646,891 8.200% |
565,946 (+7.00%) |
Filing History |
| 2024-02-22 2:26 pm Purchase |
2024-02-09 | 13G | Applied Therapeutics, Inc. APLT |
Propel Bio Management LLC | 8,071,526 10.500% |
3,314,144 (+69.66%) |
Filing History |
| 2024-02-14 9:20 pm Purchase |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III L.P. | 7,877,817 9.990% |
2,080,232 (+35.88%) |
Filing History |
| 2024-02-14 6:30 pm Sale |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
ORBIMED ADVISORS LLC | 0 0.000% |
-7,300,921 (Position Closed) |
Filing History |
| 2024-02-14 4:52 pm Unchanged |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Perceptive Advisors LLC | 4,580,249 5.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:22 pm Sale |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
ALEXANDRIA REAL ESTATE EQUITIES INC. ARE |
12,859,054 15.400% |
-575,000 (-4.28%) |
Filing History |
| 2024-02-14 2:40 pm Sale |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Armistice Capital, LLC | 0 0.000% |
-5,333,951 (Position Closed) |
Filing History |
| 2024-02-14 1:50 pm Purchase |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Alyeska Investment Group, L.P. | 7,715,197 9.990% |
2,910,197 (+60.57%) |
Filing History |
| 2024-02-13 4:34 pm Purchase |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Vestal Point Capital, LP | 4,155,000 5.400% |
4,155,000 (New Position) |
Filing History |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Applied Therapeutics, Inc. APLT |
FMR LLC | 2,427,436 3.143% |
-544,935 (-18.33%) |
Filing History |
| 2024-02-06 08:49 am Sale |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
FRANKLIN RESOURCES INC BEN |
7,793,912 9.990% |
-76,785 (-0.98%) |
Filing History |
| 2023-12-11 12:29 pm Sale |
2023-11-30 | 13G | Applied Therapeutics, Inc. APLT |
FRANKLIN RESOURCES INC BEN |
7,870,697 10.200% |
-76,035 (-0.96%) |
Filing History |
| 2023-12-06 4:15 pm Purchase |
2023-12-04 | 13G | Applied Therapeutics, Inc. APLT |
Perceptive Advisors LLC | 4,580,249 5.900% |
4,580,249 (New Position) |
Filing History |
| 2023-11-13 5:10 pm Purchase |
2023-11-09 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 8,080,945 10.100% |
5,568 (+0.07%) |
Filing History |
| 2023-05-10 12:03 pm Purchase |
2023-04-30 | 13G | Applied Therapeutics, Inc. APLT |
FRANKLIN RESOURCES INC BEN |
7,946,732 16.500% |
3,171,248 (+66.41%) |
Filing History |
| 2023-05-08 4:05 pm Purchase |
2023-04-26 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III L.P. | 5,797,585 9.990% |
5,797,585 (New Position) |
Filing History |
| 2023-05-02 1:24 pm Purchase |
2023-02-28 | 13G | Applied Therapeutics, Inc. APLT |
Propel Bio Management LLC | 4,757,382 9.900% |
4,757,382 (New Position) |
Filing History |